Quadrant Capital Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,965
| Closed | -$30.9K | – | 2787 |
|
|
2024
Q1 | $30.9K | Hold |
1,965
| – | – | ﹤0.01% | 1655 |
|
|
2023
Q4 | $31.7K | Buy |
1,965
+40
| +2% | +$645 | ﹤0.01% | 1610 |
|
|
2023
Q3 | $24.5K | Hold |
1,925
| – | – | ﹤0.01% | 1609 |
|
|
2023
Q2 | $27.1K | Hold |
1,925
| – | – | ﹤0.01% | 1566 |
|
|
2023
Q1 | $29.7K | Hold |
1,925
| – | – | ﹤0.01% | 1498 |
|
|
2022
Q4 | $31.6K | Sell |
1,925
-210
| -10% | -$3.44K | ﹤0.01% | 1430 |
|
|
2022
Q3 | $39K | Buy |
2,135
+159
| +8% | +$2.9K | 0.01% | 1184 |
|
|
2022
Q2 | $26K | Buy |
1,976
+39
| +2% | +$513 | ﹤0.01% | 1181 |
|
|
2022
Q1 | $18K | Sell |
1,937
-1,915
| -50% | -$17.8K | ﹤0.01% | 1394 |
|
|
2021
Q4 | $38K | Buy |
3,852
+3,823
| +13,183% | +$37.7K | ﹤0.01% | 1032 |
|
|
2021
Q3 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 2430 |
|